RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience

RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience
Near Frontier
RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience
Episode 2 January 25, 2022 00:43:57

Show Notes

Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology. 



  1. Sixfold Bioscience and challenges with RNA delivery 
  2. How George and Anna started Sixfold
  3. Switching between an academia and entrepreneurship mindset
  4. Building a biotech totally from scratch
  5. Twitter debate—founder led bio vs venture incubation 
  6. Building a diverse (majority women!) team and tips for recruitment
  7. Sixfold's big vision
  8. Broader trends to be excited about in biotech and deep tech

Other Episodes

April 05, 2022

Scaling Robotics with Tessa Lau of Dusty Robotics

Today we're joined by Tessa Lau, founder and CEO of Dusty Robotics, a Bay Area construction robotics company. We talk to Tessa about the vision for Dusty, how she got started, dealing with supply chain, selling into construction, and her advice for new deep tech founders. If you're interested in robotics, construction, or building hardware startups, then this episode is for you.    Dusty Robotics twitter Dusty Robotics website Tessa Lau twitter Dusty Robotics tik tok videos  ...



August 24, 2022

The Fourth Pillar of Cancer w/ Anand Parikh of Faeth Therapeutics

Today we're joined by Anand Parikh, founder and CEO of Faeth Therapeutics. Faeth combines precision nutrition, therapeutics, and digital health to deliver a cancer-fighting program designed to deprive tumors of the nutrients they need to grow while providing optimal nutritional support to healthy tissues.  In this episode, we get into what led Anand to start Faeth, dig into the operational complexity behind the business's software, therapeutics, and nutrition aspects, discuss fundraising for an unconventional business model, and more.  Get in touch— Anand's socials Enroll in Faeth's clinical trials here Check out Faeth's open roles here   ...



October 11, 2022

Building the BioForge w/ Sean Hunt of Solugen

We're lucky to have Sean Hunt, cofounder of Solugen, with us on Near Frontier today. We talk to Sean about the evolution of clean tech into synthetic biology, what makes Solugen special, how to build a revenue generating hard tech business, and more. Deep tech founders and investors, this is one where you'll want to pull out your notepads.   Solugen website Solugen twitter Sean's twitter ...